(The Liberty Loft) A study released this week in the American Heart Association’s (AHA) publication Circulation found that young patients who experienced myocarditis were overwhelmingly injected with an experimental mRNA COVID-19 shot within a month of the heart condition starting.
The study looked at data on 139 adolescent or young adult patients, all under 21 years old, “with suspected myocarditis within 30 days of COVID-19 vaccination” from 26 healthcare centers in America.
The study states: “Understanding the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination has important public health implications in the decision to vaccinate youth.”
It found that 136, or 97.8%, has received an mRNA shot and 131, or 91.4%, after a Pfizer jab with 128, or 91.4%, coming after the second jab. The median age was 15.8 with males (126, or 90.6%) making up the largest share. Symptoms generally started within 2 days of being jabbed, and chest pains (99.3%) were the most common symptom.
The study looked at cardiac magnetic resonance imaging (cMRI)
In its conclusion, the study states: “Abnormal findings on cMRI were frequent. Future studies should evaluate risk factors, mechanisms, and long-term outcomes.”
This article appears in its entirety at the Liberty Loft. Read it here. Note: Title changed by the Montana Daily Gazette.